Guangli Yang Selected Research

fluoresceinated methotrexate (FMTX)

2/2005	An 19F magnetic resonance-based in vivo assay of solid tumor methotrexate resistance: proof of principle.
10/2003	A fluorine-labeled methotrexate as a probe for monitoring tumor antifolate pharmacokinetics: synthesis, in vitro cytotoxicity, and pilot in vivo 19F magnetic resonance spectra.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guangli Yang Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 10/2003
6	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2003
2	Tuberculosis (Tuberculoses) 10/2021 - 02/2015
2	Glioma (Gliomas) 01/2021 - 04/2011
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 02/2005
2	Lung Neoplasms (Lung Cancer) 09/2011 - 09/2011
2	Adenocarcinoma of Lung 09/2011 - 11/2006
2	Malaria 01/2010 - 12/2003
1	Ovarian Epithelial Carcinoma 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Brucellosis (Malta Fever) 01/2022
1	Communicable Diseases (Infectious Diseases) 10/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Fibrosarcoma 01/2021
1	Giant Cell Tumor of Tendon Sheath 01/2021
1	Bovine Brucellosis (Bang's Disease) 05/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2016
1	Brain Neoplasms (Brain Tumor) 04/2011
1	Central Nervous System Diseases (CNS Diseases) 04/2011
1	Body Weight (Weight, Body) 04/2011
1	Gliosarcoma 04/2011
1	Prostatic Neoplasms (Prostate Cancer) 04/2009
1	Pathologic Neovascularization 04/2009
1	Alzheimer Disease (Alzheimer's Disease) 01/2009
1	Breast Neoplasms (Breast Cancer) 08/2008
1	Melanoma (Melanoma, Malignant) 12/2003
1	Autoimmune Diseases (Autoimmune Disease) 12/2003

Drug/Important Bio-Agent (IBA)

2	Phosphotransferases (Kinase)IBA 01/2022 - 11/2006
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 10/2019
2	CytokinesIBA 01/2021 - 12/2003
2	Methionine (L-Methionine)FDA Link 01/2021 - 11/2006
2	ErbB Receptors (EGF Receptor)IBA 09/2011 - 11/2006
2	migrastatinIBA 09/2011 - 03/2010
2	Ether (Diethyl Ether)IBA 09/2011 - 03/2010
2	honokiolIBA 04/2011 - 08/2008
2	alpha-galactosylceramideIBA 01/2010 - 12/2003
2	C-galactosylceramideIBA 01/2010 - 12/2003
2	C-glycosideIBA 01/2010 - 12/2003
2	fluoresceinated methotrexate (FMTX)IBA 02/2005 - 10/2003
2	Folic Acid AntagonistsIBA 02/2005 - 10/2003
2	Methotrexate (Mexate)FDA LinkGeneric 02/2005 - 10/2003
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	AntigensIBA 01/2022
1	Subunit VaccinesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	HydrolasesIBA 10/2021
1	LipidsIBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Conditioned Culture MediaIBA 01/2021
1	pexidartinibIBA 01/2021
1	Attenuated VaccinesIBA 05/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2016
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2016
1	BuffersIBA 02/2015
1	Superoxide Dismutase-1IBA 09/2011
1	Biological ProductsIBA 09/2011
1	GlycolipidsIBA 01/2010
1	Metalloproteases (Metalloproteinases)IBA 04/2009
1	DisintegrinsIBA 04/2009
1	peptide deformylaseIBA 04/2009
1	Peptides (Polypeptides)IBA 01/2009
1	PresenilinsIBA 01/2009
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2008
1	liposomal honokiolIBA 08/2008
1	Tyrosine Kinase InhibitorsIBA 11/2006
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2006
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2006
1	Gefitinib (Iressa)FDA Link 11/2006
1	Threonine (L-Threonine)FDA Link 11/2006
1	Leucovorin (Folinic Acid)FDA Link 02/2005
1	Cytotoxins (Cytolysins)IBA 02/2005
1	LigandsIBA 12/2003
1	FluorineIBA 10/2003

Therapy/Procedure

5	Therapeutics 01/2022 - 02/2005
1	Immunotherapy 01/2021
1	Transplantation 12/2019
1	Intravenous Injections 04/2011